This inventor holds 26 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Abbott Laboratories Corporation, Autobahn Therapeutics, Inc., Abbvie Inc.. Active years: 1993-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- North Chicago, IL (US) (2019)
- Richmond, IL (US) (1993 - 2023)
Company Filing History:
13 out of 4,188 
6 out of 7 
3 out of 826 
Years Active: 1993-2026
Areas of Expertise:
Title: Thomas W von Geldern: Innovator in Pharmaceutical Chemistry
Introduction
Thomas W von Geldern, based in Richmond, IL, is a prolific inventor with a notable portfolio consisting of 19 patents. His work primarily focuses on advancements in pharmaceutical chemistry, contributing to the development of innovative treatments for various diseases and disorders. Through his research, von Geldern has played a pivotal role in addressing significant health challenges faced in modern medicine.
Latest Patents
Among his latest contributions, von Geldern has developed acylsulfonamide derivatives aimed at treating senescence-associated diseases and disorders. These compounds, represented by specific chemical formulas, offer potential therapeutic benefits for aging-related conditions.
Another remarkable patent involves a chiral synthesis method to produce cis-imidazoline compounds for pharmaceutical use. This innovative method enables the enantioselective synthesis of cis-imidazolines and related structures. By employing a chiral acid for selective crystallization, the method maximizes the enantiomeric excess, achieving figures as high as 99%. The cis-imidazolines produced through this process, such as Nutlin-3a, have applications in cancer treatment and therapeutic strategies for senescence-associated conditions.
Career Highlights
Throughout his career, Thomas W von Geldern has collaborated with prominent organizations in the pharmaceutical industry, including Abbott Laboratories Corporation and Unity Biotechnology, Inc. His tenure at these institutions has been marked by significant contributions to drug development and innovation in treatment methodologies.
Collaborations
Von Geldern has worked alongside several talented professionals, including Martin Winn and Steven Armen Boyd. These collaborations have fostered an environment of innovation, allowing for the exchange of ideas and expertise that further enhance the development of novel compounds.
Conclusion
In summary, Thomas W von Geldern stands out as a formidable inventor in the field of pharmaceutical chemistry, with a strong track record of patents and collaborations. His recent work not only demonstrates his commitment to advancing medical science but also highlights the importance of continued innovation in tackling some of the most pressing health challenges of our time.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile